Fresenius

(IN BRIEF) Fresenius Medical Care, a leading provider of products and services for renal diseases, celebrates International Women’s Day by honoring three exceptional employees for their outstanding achievements. Ana Catalina Alvarez Elias, a Research Scientist, has been recognized as an … Read the full press release →

(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations. This marks a significant milestone in the company’s growth strategy (#FutureFresenius) and expands treatment options for inflammatory, autoimmune diseases, and … Read the full press release →

(IN BRIEF) Fresenius, a global healthcare group, has appointed an independent advisory board to focus on sustainability issues. Comprising four experts from various fields, the board will support the development of Fresenius’ sustainability strategy. This move reflects Fresenius’ commitment to … Read the full press release →

(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth in 2024 due to the momentum from their #FutureFresenius initiatives. Achieving their raised outlook for FY/23, the company saw continued … Read the full press release →

(IN BRIEF) The Knowledge and Innovation Covenant (KIC) has awarded funding to three projects under the ‘Collaboration in mission-driven innovation’ call. These projects involve interdisciplinary consortia of knowledge institutions, private entities, and public partners. The research aims to explore ways … Read the full press release →

Study investigates interaction between dietary fat and gastrointestinal microbiota MUNICH, 24-Nov-2016 — /EuropaWire/ — Gut bacteria play a little-understood role in the body’s energy balance, which is influenced by diet. However, the crucial nutritional components are unknown. A team at the … Read the full press release →